FDA Inspection 869230 — Bieffe Medital, S.A.

Bieffe Medital, S.A. — FEI 3005164365

The FDA completed an inspection of Bieffe Medital, S.A. on February 23, 2014 in Sabinanigo. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 4 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
February 23, 2014
Fiscal Year
2014
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Sabinanigo (Spain)

Citations

IDCFRDescription
110521 CFR 211.22(d)Procedures not in writing, fully followed
117421 CFR 211.42(b)Product flow through building is inadequate
440121 CFR 211.186(b)(9)Complete instructions, procedures, specifications et. al.
440221 CFR 211.192Written record of investigation incomplete